Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1992-08-26
1993-08-17
Ivy, C. Warren
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514310, 546143, 546146, 546147, A61H 3147, C07D21716
Patent
active
052369340
ABSTRACT:
Provided are 1,2,3,4-tetrahydroisoquinolines, methods for preparing them, pharmaceutical compositions containing them, and methods of using them to treat disorders of mammals mediated by AT.sub.2 receptors in the central nervous system.
REFERENCES:
patent: 4344949 (1982-08-01), Hoefla et al.
patent: 4812462 (1989-03-01), Blankely et al.
patent: 5059608 (1991-10-01), Takasugi et al.
patent: 5091390 (1992-02-01), Ardecky et al.
Niopas, "Pharm. Delt., Epistem. Ekdosis", vol. 10, No. 1, 1984, pp. 1-15.
"Chemical Abstracts" version vol. 104, 1986, p. 688.
E. I. Du Pont de Nemours and Company
Ivy C. Warren
Turnipseed James H.
LandOfFree
1,2,3,4-tetrahydroisoquinolines useful in the treatment of CNS d does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 1,2,3,4-tetrahydroisoquinolines useful in the treatment of CNS d, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1,2,3,4-tetrahydroisoquinolines useful in the treatment of CNS d will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2243938